Emergo Therapeutics Competitors and Similar CompaniesClear all

Emergo Therapeutics's competitors and similar companies include MindMed, Siegfried Hameln and Novartis France.

	Emergo Therapeutics Emergo Therapeutics is a biopharmaceutical company specializing in developing drugs to modulate inflammatory cytokines.	MindMed MindMed is a neuro-pharmaceutical company focused on discovering and developing medicines based on psychedelics.	Siegfried Hameln Siegfried Hameln is a company that manufactures, tests, and packages medicinal products.	Novartis France Novartis France (also known as Novartis Pharma) is a company developing medical treatments.
Founding Date	Founding Date 2017	Founding Date 2019	Founding Date 1950	Founding Date 1997
Type	Type Private	Type Private	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare clinical research drug development pharma	Tags Healthcare clinical research drug development pharma	Tags Healthcare clinical research drug development pharma	Tags Healthcare clinical research drug development pharma
Locations	Locations Durham, US HQ	Locations New York, US HQ	Locations Hameln, DE HQ	Locations Rueil-Malmaison, FR HQ
Employees	Employees 5	Employees 1092% decrease	Employees 412% decrease	Employees 5282% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €100.5m (FY, 2020)	Revenue (est.) €2.3b (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €35.1m (FY, 2020)	Cost of goods €1.4b (FY, 2021)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit €65.4m (FY, 2020)	Gross profit €844.1m (FY, 2021)
Net income	Net income N/A	Net income N/A	Net income €9.6m (FY, 2020)	Net income €47m (FY, 2021)
Funding
Latest funding round	Latest funding round $ 12m (about 8 years ago)	Latest funding round $ 6.2m (almost 7 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 12m	Total funding raised $ 6.2m	Total funding raised N/A	Total funding raised N/A